Net profit of Shree Ganesh Biotech India rose 37.50% to Rs 0.33 crore in the quarter ended June 2025 as against Rs 0.24 crore during the previous quarter ended June 2024. Sales declined 61.24% to Rs 1.38 crore in the quarter ended June 2025 as against Rs 3.56 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 1.38 | 3.56 | -61 |
| OPM % | -6.52 | -3.65 | - |
| PBDT | 0.33 | 0.24 | 38 |
| PBT | 0.33 | 0.24 | 38 |
| NP | 0.33 | 0.24 | 38 |